Public Health Agency of Canada / Agence de santé publique du Canada
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m Skip all navigation -accesskey z
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
SARS
General Information
For Health Professionals
  Public Health Agency of Canada (PHAC)

Severe Acute Respiratory Syndrome (SARS):
Preliminary Epidemiological Findings as of

April 4, 2003


Summary of Disease Transmission among Probable Cases in Canada:
In Ontario, where nearly all of the probable cases in Canada have been reported, it is believed that four generations of transmission have occurred. The index case in Ontario was an individual who travelled to Hong Kong and stayed at the Metropole Hotel, where a cluster of SARS cases was subsequently identified. Upon return to Canada, disease transmission occurred in four members of the immediate and extended family. A physician who had close contact with members of this family was also diagnosed with SARS. Following this, cases were reported in individuals in a hospital setting where some of the first cases were treated. Most recently, SARS has been reported in a few of the household contacts of these hospital-associated cases.

Isolated cases of travel-related exposures have also been identified in Ontario and British Columbia. An isolated case in Ontario was reported in an individual who had travelled to Asia, but did not stay in at the Metropole Hotel. Reports of all probable cases from British Columbia have also been linked to travel-related exposures in Hong Kong. All are currently in isolation and there is no evidence of further spread in British Columbia. A Canadian with SARS [not counted in the official Canadian case count], who is currently hospitalised in Hong Kong, also stayed at the Metropole Hotel.

Nearly all of the probable cases of SARS in Ontario that occurred in individuals outside of the initial family cluster have been linked either directly or indirectly back to exposure to the first hospitalised case of SARS, on March 7, 2003. It is believed that disease transmission occurred mainly as a result of person-to-person contact. The initial hospital-associated cases are thought to have contracted the illness as a result of unprotected contact with the initial cases prior to the recognition of SARS. Subsequent transmission may have then occurred between households of these hospital-associated cases, and between other healthcare workers. To date, there has been no evidence of transmission in the general community. Furthermore, there is presently no evidence to suggest that disease transmission occurs prior to the onset of fever in a suspected or probable case of SARS.

Preliminary Descriptive Findings:
Given the information available as of April 4, 2003, the average age of probable cases in Canada is 45.6 years (n=52, range 2 to 82 years), with 37 females and 20 males. The current number of probable cases by reported symptom onset date and type of exposure is also provided (Figure).

Figure: Number of probable cases of SARS in Canada by symptom onset date and exposure type from: February 23 to April 4, 2003
(n=56, excluding 18 for whom onset dates or exposure classification are unknown)

Number of probable cases of SARS in Canada by symptom onset date and exposure type

   

Estimated Incubation Period:
While it is difficult to conclusively determine the incubation period of the etiologic agent, given the fact that many of the probable cases in Ontario may have multiple exposures, the current estimated mean incubation period is 4 days (estimated range 2 to 10 days).

Clinical Manifestations:
A summary of the clinical presentation of SARS based on the first 10 cases identified in Canada has recently been published (source: New England Journal of Medicine, http://content.nejm.org /cgi/reprint/NEJMoa030634v1.pdf). Listed in order of observed frequency are fever (10/10), nonproductive cough (10/10), shortness of breath (8/10), malaise (7/10), diarrhea (5/10), chest pain (3/10), headache (3/10), sore throat (3/10), myalgias (2/10), and vomitting (1/10). Lymphopenia, elevated lactate dehydrogenase levels, elevated aspartate amino-transferase levels and elevated creatinine kinase levels were also reported. The World Health Organisation is currently coordinating global efforts to better characterize the clinical manifestations of SARS.

Severity of Illness:
Of all the probable cases reported on April 4, 2003, most remain hospitalised for isolation purposes. Shown in the Table is the reported known status of 40 probable cases of SARS that are currently hospitalised, or were subsequently discharged, as of April 4, 2003. Please note that these numbers are based on preliminary data, and will be updated accordingly as more information becomes available. All seven deaths reported to date have been associated with individuals with underlying illness and all but two have occurred in elderly patients over the age of 70.

Table: Reported known status of currently hospitalised or subsequently discharged probable cases of SARS in Canada: April 4, 2003
(n=40, excluding 7 deaths and 27 individuals whose status is currently unknown)

Status Number of Cases Proportion
Discharged 8 20 %
Improving 6 15 %
Stable 22 55 %
Deteriorating 2 5 %
Critical 2 5 %
Total Number of Probable Cases with Known Status, Currently Hospitalised or Discharged 40 100 %



[Severe Acute Respiratory Syndrome (SARS)]


Last Updated: 2003-04-06 Top